Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for actions of estrone distinct from those of estradiol.

The Journal of clinical endocrinology and metabolism·2026
Same author

Neuron-Enriched Extracellular Vesicle MicroRNAs Reflect Hormone-Sensitive Neural Pathway Changes from Early to Late Perimenopause.

medRxiv : the preprint server for health sciences·2026
Same author

Report of the FDA's expert panel on hormone therapy.

Menopause (New York, N.Y.)·2026
Same author

Obesity in menopause care.

European journal of endocrinology·2026
Same author

Menopausal Symptom Management in Patients After Risk-Reducing Oophorectomy.

Obstetrical & gynecological survey·2025
Same author

European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause.

European journal of endocrinology·2025

Related Experiment Video

Updated: May 31, 2026

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
07:28

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery

Published on: February 3, 2026

Pharmacological therapy for abnormal uterine bleeding.

JoAnn V Pinkerton1

  • 1Department of Obstetrics and Gynecology, Division of Midlife Health, University of Virginia Health System, Charlottesville, VA 22908, USA. jvp9u@virginia.edu

Menopause (New York, N.Y.)
|June 25, 2011
PubMed
Summary
This summary is machine-generated.

Pharmacological treatments effectively manage abnormal uterine bleeding. Options range from nonhormonal agents like NSAIDs and tranexamic acid to hormonal therapies, with selection based on individual patient needs and bleeding characteristics.

Related Experiment Videos

Last Updated: May 31, 2026

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
07:28

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery

Published on: February 3, 2026

Area of Science:

  • Gynecology
  • Pharmacology

Background:

  • Abnormal uterine bleeding (AUB) is a common gynecological condition.
  • Effective pharmacological therapies are available and generally well-tolerated.

Purpose of the Study:

  • To present an evidence-based approach to medical therapy for abnormal uterine bleeding.
  • To guide selection of pharmacological agents based on etiology, bleeding amount, fertility needs, and patient status.

Main Methods:

  • Review of available nonhormonal agents including nonsteroidal anti-inflammatory drugs (NSAIDs), tranexamic acid, and desmopressin.
  • Review of hormonal regimens such as cyclic progestogens, oral contraceptives, progestin-releasing intrauterine devices, long-acting progestogen injections, danazol, and gonadotropin agonists.

Main Results:

  • Nonhormonal agents: NSAIDs reduce bleeding 25-35%; tranexamic acid reduces blood loss 40-60%; desmopressin is for bleeding disorders.
  • Hormonal agents: Oral contraceptives reduce bleeding 40-50%; progestin-IUDs are up to 97% effective; danazol causes endometrial atrophy; GnRH agonists shrink fibroids/endometrium.

Conclusions:

  • Pharmacological therapy selection for AUB requires consideration of etiology, bleeding severity, fertility preservation, and patient-specific factors.
  • Both hormonal and nonhormonal agents offer effective management options with varying benefits and side effect profiles.